Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS
Analytical Chemistry · 11.04.2023 · 95 (14) · 5994-6001
DOI: 10.1021/acs.analchem.2c05807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 30.03.2023. Verfasst von Wenshi He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Analytical Bioscience, Advanced Materials & Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7…. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, University of Nottingham.
Abstract (Originalsprache)
Glioblastoma (GBM) is an incurable brain cancer with a median survival of less than two years from diagnosis. The standard treatment of GBM is multimodality therapy comprising surgical resection, radiation, and chemotherapy. However, prognosis remains poor, and there is an urgent need for effective anticancer drugs. Since different regions of a single GBM contain multiple cancer subpopulations ("intra-tumor heterogeneity"), this likely accounts for therapy failure as certain cancer cells can escape from immune surveillance and therapeutic threats. Here, we present metabolomic data generated using the Orbitrap secondary ion mass spectrometry (OrbiSIMS) technique to investigate brain tumor metabolism within its highly heterogeneous tumor microenvironment. Our results demonstrate that an OrbiSIMS-based untargeted metabolomics method was able to discriminate morphologically distinct regions (viable, necrotic, and non-cancerous) within single tumors from formalin-fixed paraffin-embedded tissue archives. Specifically, cancer cells from necrotic regions were separated from viable GBM cells based on a set of metabolites including cytosine, phosphate, purine, xanthine, and 8-hydroxy-7-methylguanine. Moreover, we mapped ubiquitous metabolites across necrotic and viable regions into metabolic pathways, which allowed for the discovery of tryptophan metabolism that was likely essential for GBM cellular survival. In summary, this study first demonstrated the capability of OrbiSIMS for in situ investigation of GBM intra-tumor heterogeneity, and the acquired information can potentially help improve our understanding of cancer metabolism and develop new therapies that can effectively target multiple subpopulations within a tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Analytical Bioscience, Advanced Materials & Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.
- Department of Chemical and Environmental Engineering, Faculty of Engineering, University of Nottingham, Nottingham NG7 7RD, U.K.
- Neuropathology Laboratory, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, U.K.
- Children's Brain Tumour Research Centre, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 2RD, U.K.
ORCID-Profile: Wenshi He, Max K Edney, Rian L Griffiths, David J Scurr, Ruman Rahman, Dong-Hyun Kim
Förderung
- Engineering and Physical Sciences Research Council
- University of Nottingham
Zitieren
APA
He, W., Edney, M. K., Paine, S. M. L., Griffiths, R. L., Scurr, D. J., Rahman, R., & Kim, D. H. (2023). Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS. Analytical Chemistry, 95(14), 5994-6001. https://doi.org/10.1021/acs.analchem.2c05807
Vancouver
He W, Edney MK, Paine SML, Griffiths RL, Scurr DJ, Rahman R, et al. Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS. Analytical Chemistry. 2023;95(14):5994-6001. doi:10.1021/acs.analchem.2c05807
BibTeX
@article{He2023,
author = {He, Wenshi and Edney, Max K and Paine, Simon M L and Griffiths, Rian L and Scurr, David J and Rahman, Ruman and Kim, Dong-Hyun},
title = {Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS},
journal = {Analytical Chemistry},
year = {2023},
volume = {95},
number = {14},
pages = {5994--6001},
doi = {10.1021/acs.analchem.2c05807}
}
EUVIMED